COVID-19 case dies from blood clot in lung artery more than 2 weeks after recovery, discharge: MOH

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

SINGAPORE: A 41-year-old man died from complications due to COVID-19 more than two weeks after recovering from the disease and being discharged, ...

SINGAPORE: A 41-year-old man died from complications due to COVID-19 more than two weeks after recovering from the disease and being discharged, the Ministry of Health said on Saturday .

A pulmonary embolism happens when there is a blockage in a pulmonary artery located in the lungs, according to the SingHealth website. In most cases, this blockage is caused by blood clots, it said. Thromboembolism is defined as the obstruction of a blood vessel by a blood clot that had become dislodged from another site in the circulation."Twenty-five have passed away from complications due to COVID-19 infection," the health ministry added.Health Minister Gan Kim Yong said on Thursday that an advisory was issued to all doctors on May 20 to be"watchful" for possible cardiovascular issues in COVID-19 patients.

COVID-19 patients who are admitted to the intensive care unit are at higher risk because they are “immobile for prolonged periods and may have multiple co-mordidities”, said Mr Gan, citing international data.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

No plan to treat Covid-19 patients in Singapore with hydroxychloroquineSingapore does not plan to use hydroxychloroquine to treat patients with Covid-19, even though the World Health Organisation (WHO) plans to restart the trial of this drug.. Read more at straitstimes.com. Think the key word is outpatient within 72 hrs with zinc,and dosage . Once you are critically ill, 50/50 percent and maybe Remdesivir is more effective. I would love to know if HCQ was given to outpatients Lancet study was retracted... pls test HCQ asap
Source: The Straits Times - 🏆 8. / 63 Read more »